A phase ii trial of oral estramustine and oral etoposide in hormone refractory prostate cancer

199794 citationsJournal Article

Authors

Good health and well-being

Published in: Urology

Volume 50, Issue 3, pp. 401-407

Field-Weighted Citation Impact: 7.73